癌におけるRAI14の役割:生物学的意義と翻訳的展望
PubMedで要約を見る
まとめ
この要約は機械生成です。レチノ酸誘発タンパク質14 (RAI14) は,重要な細胞プロセスに影響することによって,10種類以上の癌に関与しています. 腫瘍におけるその調節不全と過剰発現は,診断用バイオマーカーと治療用標的の可能性を示唆する.
科学分野
- 腫瘍学
- 分子生物学
- 細胞生物学
背景
- レチノ酸誘発タンパク質14 (RAI14) は,細胞動態に影響を与えるアクチン結合タンパク質である.
- RAI14の調節障害は少なくとも10の異なる腫瘍の発生と関連しています.
- 既存の文献には,様々な癌におけるRAI14の特定の役割に関する包括的なレビューがない.
研究 の 目的
- RAI14の既知の腫瘍調節機能を,様々な癌のタイプで統合し,検討する.
- 腫瘍形成におけるRAI14による分子経路を強調する.
- 腫瘍学におけるバイオマーカーおよび治療標的としてのRAI14の可能性を調査する.
主な方法
- RAI14と癌に焦点を当てた20以上のオリジナルの研究論文の文献レビュー.
- AKT,mTOR,Hippo,apoptosis,EMTを含むRAI14によって影響を受けた分子経路の分析
- 非コーディングRNA (例えば,miR-23b-3p,AFAP1-AS1) によってRAI14の表遺伝子調節の検討.
主要な成果
- RAI14はAKT,mTOR,イエス関連タンパク質/ヒッポ経路,アポトーシス,および上皮からメゼンキマへの移行を調節することによって腫瘍形成に影響を与えます.
- miR-23b-3pやAFAP1-AS1のような非コーディングRNAは,RAI14の発現と機能を表遺伝的に調節する.
- RAI14は,乳がん,胃腸がん,泌尿器がん,脳がんを含む,少なくとも7つのヒトがんで過剰発現しており,バイオマーカーの可能性を示しています.
結論
- RAI14は様々な癌の発生と進行に多面的に重要な役割を果たします.
- RAI14は,多種多様な腫瘍の過剰発現により,診断および予後バイオマーカーとしての可能性を示しています.
- RAI14を標的とした治療は有望な治療戦略であり,バイオマーカーと治療の応用に関するさらなる臨床研究が必要である.
関連する概念動画
The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a...
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
RNA interference (RNAi) is a cellular mechanism that inhibits gene expression by suppressing its transcription or activating the RNA degradation process. The mechanism was discovered by Andrew Fire and Craig Mello in 1998 in plants. Today, it is observed in almost all eukaryotes, including protozoa, flies, nematodes, insects, parasites, and mammals. This precise cellular mechanism of gene silencing has been developed into a technique that provides an efficient way to identify and determine the...
In humans, more than 80% of the genome gets transcribed. However, only around 2% of the genome codes for proteins. The remaining part produces non-coding RNAs which includes ribosomal RNAs, transfer RNAs, telomerase RNAs, and regulatory RNAs, among other types. A large number of regulatory non-coding RNAs have been classified into two groups depending upon their length – small non-coding RNAs, such as microRNA, which are less than 200 nucleotides in length, and long non-coding RNA...
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...

